Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck.
Haddad R, Wirth L, Costello R, Weeks L, Posner M. Haddad R, et al. Among authors: posner m. Semin Oncol. 2003 Dec;30(6 Suppl 18):84-8. doi: 10.1053/j.seminoncol.2003.11.011. Semin Oncol. 2003. PMID: 14727246 Clinical Trial.
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.
Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Haddad R, et al. Among authors: posner m. Cancer. 2003 Jan 15;97(2):412-8. doi: 10.1002/cncr.11063. Cancer. 2003. PMID: 12518365 Free article.
Emerging drugs for head and neck cancer.
Haddad R, Wirth L, Posner M. Haddad R, et al. Among authors: posner m. Expert Opin Emerg Drugs. 2006 Sep;11(3):461-7. doi: 10.1517/14728214.11.3.461. Expert Opin Emerg Drugs. 2006. PMID: 16939385 Review.
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB. Haddad R, et al. Among authors: posner m. Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525. Cancer. 2009. PMID: 19634161 Free article. Clinical Trial.
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck.
Wirth LJ, Allen AM, Posner MR, Haddad RI, Li Y, Clark JR, Busse PM, Chan AW, Goguen LA, Norris CM, Annino DJ, Tishler RB. Wirth LJ, et al. Among authors: posner mr. Ann Oncol. 2010 Feb;21(2):342-347. doi: 10.1093/annonc/mdp477. Epub 2009 Nov 5. Ann Oncol. 2010. PMID: 19892746 Free article. Clinical Trial.
1,138 results